These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 1683191)

  • 1. Controlled trial of H1 antagonists in the treatment of chronic idiopathic urticaria.
    Sussman G; Jancelewicz Z
    Ann Allergy; 1991 Oct; 67(4):433-9. PubMed ID: 1683191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria.
    Boggs PB; Ellis CN; Grossman J; Washburne WF; Gupta AK; Ball R; Shulan D
    Ann Allergy; 1989 Dec; 63(6 Pt 2):616-20. PubMed ID: 2574555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis.
    Monroe EW
    Clin Ther; 1992; 14(1):17-21. PubMed ID: 1349509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria.
    Salo OP; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():18B-21B. PubMed ID: 2569996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged benefit in the treatment of chronic idiopathic urticaria with astemizole.
    Honsinger RW; Thomsen RJ
    Ann Allergy; 1990 Sep; 65(3):194-200. PubMed ID: 1976298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria.
    Brostoff J; Fitzharris P; Dunmore C; Theron M; Blondin P
    Allergy; 1996 May; 51(5):320-5. PubMed ID: 8836336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined H1 and H2 antihistamine therapy in chronic urticaria.
    Monroe EW; Cohen SH; Kalbfleisch J; Schulz CI
    Arch Dermatol; 1981 Jul; 117(7):404-7. PubMed ID: 6114712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria.
    Monroe EW; Bernstein DI; Fox RW; Grabiec SV; Honsinger RW; Kalivas JT; Katz HI; Cuss F; Danzig MR; Garvin PR
    Arzneimittelforschung; 1992 Sep; 42(9):1119-21. PubMed ID: 1445478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria. A placebo-controlled study.
    Kobza Black A; Aboobaker J; Gibson JR; Harvey SG; Marks P
    Acta Derm Venereol; 1988; 68(6):541-4. PubMed ID: 2467496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients].
    Paul E; Bödeker RH
    Z Hautkr; 1985; 60 Suppl 1():50-5. PubMed ID: 2859714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the efficacy and tolerance of cetirizine verses astemizole in patients with allergic rhinitis].
    Barthe P; Gómez JR; Suárez C; Ferro S; Figueres B
    Acta Otorrinolaringol Esp; 1992; 43(3):183-7. PubMed ID: 1355345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients.
    Paul E; Bödeker RH
    Ann Allergy; 1989 Apr; 62(4):318-20. PubMed ID: 2565098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria.
    Cainelli T; Seidenari S; Valsecchi R; Mosca M
    Pharmatherapeutica; 1986; 4(10):679-86. PubMed ID: 2885854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists.
    Lin RY; Curry A; Pesola GR; Knight RJ; Lee HS; Bakalchuk L; Tenenbaum C; Westfal RE
    Ann Emerg Med; 2000 Nov; 36(5):462-8. PubMed ID: 11054200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
    Dubertret L; Murrieta Aguttes M; Tonet J
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial.
    Pons-Guiraud A; Nekam K; Lahovsky J; Costa A; Piacentini A
    Eur J Dermatol; 2006; 16(6):649-54. PubMed ID: 17229605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind multicenter controlled clinical study comparing the efficacy of picumast dihydrochloride versus astemizole and placebo in patients with seasonal allergic rhinitis.
    Franke W; Messinger D
    Arzneimittelforschung; 1989 Oct; 39(10A):1360-3. PubMed ID: 2576364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
    Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of urticaria with the new H1 antihistaminic astemizole--with special reference to the time of onset of effect and maximum effect].
    Kurz K
    Z Hautkr; 1986 Nov; 61(22):1646-53. PubMed ID: 2880431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astemizole in combination with pseudoephedrine in the treatment of seasonal allergic rhinitis.
    Simola M; Böss I; Holopainen E; Malmberg H; Ruoppi P; Seppä J; Siivonen L; Suonpää J; Piepponen T
    Rhinology; 1996 Mar; 34(1):21-3. PubMed ID: 8739863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.